ANIMAUX DE COMPAGNIE
CHEVAUX
Animaux de ferme
Connexion
Devenir membre
En
ANIMAUX
DE COMPAGNIE
CHEVAUX
Animaux
de ferme
Éducation
Académie féline
CommuniQUIZ
Derrière la croquette
Études de cas
NutriQUIZ
ScientiFlash
Tech vet
Vetspresso
Webdiffusions
Nouvelles et produits
Le présentoir
Nouvelles
Outils
Envol!
Outils pour les cliniques
Plan de match
A revolution in feline diabetes mellitus care! Novel drugs and new recommendations
Presented by Susan Little, DVM, Dipl. ABVP
Continuing education questionnaire
CE credit: 1
AssignedWebcast
Select an entry
Une révolution dans les soins du diabète sucré félin! De nouveaux médicaments et de nouvelles recommandations
Nom
Prénom
*
Nom de famille
*
Numéro de permis
*
Province where you practise - [FR]
*
Courriel
*
Questions
1. Which of the following statements is false?
*
Multimorbidity is common in senior cats
Our priorities for a patient always align with the owner’s priorities
Health literacy is a challenge for owners
2. Which of the following is an important component of intensive management with insulin?
*
The patient is newly diagnosed
The patient is less than 8 years of age
The patient weighs less than 7 kg
3. Which of the following is associated with “loose” insulin management protocols?
*
Blood glucose curves are not necessary
The cost is the same as for standard management protocols
Remission is highly likely within 4 weeks
4. Which of the following is not associated with diabetes management foods?
*
Improved glycemic control
Lower insulin doses
Increased chance of remission
5. Sodium-glucose cotransporter-2 (SGLT2) inhibitor drugs control hyperglycemia by:
*
Promoting glucose absorption in renal tubules
Completely blocking glucose reabsorption in renal tubules
Promoting urinary glucose excretion
6. Which of the following adverse effects is rare when using SGLT2 inhibitor drugs?
*
Diarrhea
Diabetic ketoacidosis
Hypoglycemia
7. Which of the following is true about diabetic ketoacidosis with SGLT2 inhibitor treatment of diabetes in cats?
*
It is most likely to occur within the first 14 days of treatment
It never occurs after 1 month of treatment
It always occurs between 18–20 days of treatment
8. SGLT2 inhibitor drugs should not be given to cats with which of the following conditions?
*
Behaviour problems
Chronic pancreatitis
Food intolerance dermatitis
9. Which of the following is a feature of euglycemia diabetic ketoacidosis?
*
Metabolic alkalosis
Ketonemia
Hyperglycemia
10. Which of the following is necessary for successful treatment of feline diabetes with SGLT2 inhibitor drugs?
*
Sufficient endogenous insulin
Elevated pancreatic lipase
Normal serum fructosamine
Soumettre
ANIMAUX
DE COMPAGNIE
CHEVAUX
Animaux
de ferme
Éducation
Académie féline
CommuniQUIZ
Derrière la croquette
Études de cas
NutriQUIZ
ScientiFlash
Tech vet
Vetspresso
Webdiffusions
Nouvelles et produits
Le présentoir
Nouvelles
Outils
Envol!
Outils pour les cliniques
Plan de match
Connexion
Devenir membre
En
En